ISIvar Skeie

Ivar Skeie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ivar Skeie has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    LAR-behandling gir redusert sykelighet

    by Ivar Skeie

    Opioidavhengige som får legemiddelassistert rehabilitering, blir mindre plaget av rusrelatert sykdom. Det viser en ny norsk studie.

  • Open Access

    Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study

    by Ivar Skeie, Mette Brekke, Michael Gossop, Morten Lindbaek, Even Reinertsen, Magne Thoresen, Helge Waal

    Objectives To examine the effect of opioid maintenance treatment (OMT) on somatic morbidity in a cohort of OMT patients. Design Retrospective cohort study. Setting OMT programme in two Norwegian counties. Participants 200 OMT patients, participation rate 71.2%. Main outcome measures Incidence rates (IR) before, during and after OMT for acute/subacute hospital-treated somatic disease incidents (drug-related, non-drug-related, injuries) and rates for inpatient days and outpatient treatment contacts. Results IR for drug-related hospital treatment episodes were 76% lower during compared to before OMT (before versus during incidence rate ratio (IRR) 4.2 (95% CI 2.9 to 6.2), pConclusion Acute/subacute drug-related somatic morbidity is reduced during compared to before OMT. This was also found for patients with on-going drug-taking during OMT. However, acute drug-related health problems show an increase after OMT cessation, and this is a matter of concern. Further studies on somatic morbidity after OMT cessation should be carried out.


  • Open Access

    Minneord

    by Morten Lindbæk, Ivar Skeie, Johanne Sundby, Elisabeth Swensen, Einar Zwaig

  • Open Access

    Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study

    by Ivar Skeie, Mette Brekke, Morten Lindbæk, Helge Waal

    The long-term impact of opioid maintenance treatment (OMT) on morbidity and health care utilization among heroin addicts has been insufficiently studied. The objective of this study was to investigate whether health care utilization due to somatic disease decreased during OMT, and if so, whether the reduction included all kinds of diseases and whether a reduction was related to abstinence from drug use.


    • 1 February 2007
      • Vol. 127  (3) , 296-7

    [General practitioners can take responsibility for medication-based rehabilitation].

    by Ivar Skeie, Mette Brekke, Morten Lindbaek, Helge Waal

    In Gjoevik, a Norwegian town with 28,000 inhabitants, general practitioners (GPs) have taken more responsibility for Methadone Maintenance Treatment (MMT) of heroin addicts than usual in Norway. We have assessed the treatment results in Gjoevik by comparing the fraction of patients who continue with treatment (retention in treatment, from 1999 to 2003), frequency of patient contact with professionals and the treatment outcome with the results for the rest of Norway. In Norway, annual treatment results are reported for every MMT patient and the results are entered into a national register. This study is based on data in the national register from 2003. Retention is significantly higher in Gjoevik (93% vs. 77%) than in the rest of Norway. Patients have more contact with their GP in Gjoevik, while contact with local social service and so-called "responsibility groups" (organised cooperation between patient and professionals) are on the same level as for the country as a whole. The patients have less contact with specialized substance abuse and MMT centres than the average Norwegian patient. Treatment outcome regarding social rehabilitation (housing, source of income, occupation) and control of addictive behaviour (injecting drugs, opiate and illegal benzodiazepines in urine tests and overall assessment of drug behaviour) is close to the national average. This may indicate that MMT programs with considerable delegation of treatment responsibility to GPs and local social service, can function as well as programs that rely more on specialised MMT-centres.